SB 706504
SB 706504 is a potent p38 MAPK inhibitor that inhibits Lipopolysaccharides (HY-D1056)-stimulated inflammatory gene expression in macrophages in chronic obstructive pulmonary disease (COPD).
For research use only. We do not sell to patients.
- CAS No.: 911110-38-8
- Formula: C24H19F3N8O
- Molecular Weight:492.46
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
SB 706504(3 μM, 6 h) significantly reduces IL-1β, IL-6, GM-CSF, TNFα and IL-8 mRNA levels in LPS-stimulated monocyte derived macrophages (MDMs) cells[1].
SB 706504(3 μM, 6 h) can significantly reduce the level of TNFα induced by LPS in alveolar macrophages (AMs) cells of COPD patients, with an inhibition rate of 67.4%[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 911110-38-8
-
Molecular Weight 492.46
-
Formula C24H19F3N8O
-
SMILES
N=C(NCCNC1=NC(C2=CC=C(F)C=C2C)=C(C=CC(N3C4=C(F)C=CC=C4F)=O)C3=N1)NC#N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)